Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Jacques

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Transplantation Proceedings|April 1, 1988
Characterization of a factor active on eosinophils and the red cell lineageJ F Moreau, A Godard, M Bonneville, et al.
Nature|May 26, 1994
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signallingY Nakamura, S M Russell, S A Mess, et al.
Transplantation Proceedings|April 1, 1988
Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptorP Peyronnet, B Le Mauff, M Hourmant, et al.
Cytokine|January 1, 1993
Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokineA Godard, F Fauchet, S Raher, et al.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
The Journal of Biological Chemistry|July 25, 1993
Secretion of disulfide-linked human T-cell receptor gamma delta heterodimersF Davodeau, I Houde, G Boulot, et al.
Research in Immunology|December 16, 1998
The interleukin-11/receptor complex: rational design of agonists/antagonists and immunoassays potentially useful in human therapyY Jacques, S Minvielle, G Müller-Newen, et al.
Transplantation Proceedings|February 1, 1993
Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptorH Vie, T Gauthier, R Breathnach, et al.
The Journal of Biological Chemistry|October 19, 2001
Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domainsJ L Taupin, P Legembre, J Bitard, et al.
The New England Journal of Medicine|January 6, 1994
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndromeJ Dantal, E Bigot, W Bogers, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Transplantation Proceedings|April 1, 1988
Characterization of a factor active on eosinophils and the red cell lineageJ F Moreau, A Godard, M Bonneville, et al.
Nature|May 26, 1994
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signallingY Nakamura, S M Russell, S A Mess, et al.
Transplantation Proceedings|April 1, 1988
Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptorP Peyronnet, B Le Mauff, M Hourmant, et al.
Cytokine|January 1, 1993
Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokineA Godard, F Fauchet, S Raher, et al.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
The Journal of Biological Chemistry|July 25, 1993
Secretion of disulfide-linked human T-cell receptor gamma delta heterodimersF Davodeau, I Houde, G Boulot, et al.
Research in Immunology|December 16, 1998
The interleukin-11/receptor complex: rational design of agonists/antagonists and immunoassays potentially useful in human therapyY Jacques, S Minvielle, G Müller-Newen, et al.
Transplantation Proceedings|February 1, 1993
Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptorH Vie, T Gauthier, R Breathnach, et al.
The Journal of Biological Chemistry|October 19, 2001
Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domainsJ L Taupin, P Legembre, J Bitard, et al.
The New England Journal of Medicine|January 6, 1994
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndromeJ Dantal, E Bigot, W Bogers, et al.
Pageof 13